September 23, 2026 — RNews

#immunogenicity — Wednesday, September 23, 2026 (1 items)

hot top new

← prev day next day →

0

Safety and immunogenicity of a recombinant vesicular stomatitis virus-based Sudan virus vaccine in adults in the USA: a single-blind, first-in-human, dose-escalation phase 1 clinical trial. (linkinghub.elsevier.com)

Laufer DS … Gupta SB Lancet Microbe 2026-09-23

#vaccination #clinical trial #immunogenicity #safety #hemorrhagic fever